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Introduction
Abdominal aortic aneurysms can either be treated
using open methods or endovascular stent grafts.
Nevertheless, until the UK EVAR randomised con-
trolled trials report, we do not know which, if either,
of these two methodologies is preferable for the
treatment of these patients.
Endovascular aneurysm repair can produce
acceptable rates of peri-operative morbidity and
mortality, but appears to require an increased level
of intervention during the follow-up period. Such
intervention is primarily targeted at the treatment of
endo-leaks, limb occlusion and device disintegration.
Stent graft infection is a rare occurrence.
Case Report
A 67 years old male (122 kg) was treated for a 9 cm
abdominal aortic aneurysm using a Talent bifurcated
modular stent graft. The procedure was performed in
a sterile operating theatre, equipped with fixed
radiological imaging facilities. Prior to stent graft
insertion, the patient received 5000 IU Heparin
and routine prophylactic antibiotics (Cefuroxime
1.5 mg £ 3). The procedure was uncomplicated (2 h),
blood loss was minimal (100 ml) and the post-
operative stay was three days.
Follow-up was performed according to the Eurostar
protocol (CT scans at discharge, 3, 6, 12, 18, 24 and 36
months). All scans were normal with no evidence of
endo-leak, or graft disruption. The patient was
reviewed after each scan and remained well.
Three and a half years after aneurysm repair the
patient was admitted as an emergency with diabetic
keto-acidosis, having not previously been known to be
diabetic. This responded to treatment, however, his
C-reactive protein (CRP) remained elevated at
.200 mg/l. A CT scan revealed evidence of a
contained rupture (para-aortic haematoma) with
several pockets or gas both around the stent and
within the haematoma, indicating infection (Fig. 1).
At laparotomy a large right sided abscess was
found containing pus and old haematoma. A supra-
renal aortic clamp was required and the aorta opened
to allow removal of the infected stent graft. Due to a
short (peri-renal) aneurysm neck, it was not possible to
suture off the aorta and perform an extra-anatomical
bypass. Aztreonam (2 g), clindamycin (600 mg) and
metronidazole (500 mg) were intravenously admini-
strated and the aneurysm repaired using a silver
impregnated bifurcate dacron graft.
Post-operative recovery was satisfactory, serum
creatinine rising to a maximum of 150 before falling
to pre-operative levels of 110. The CRP fell from
165 mg/l (pre-operatively) to 80 mg/l by the second
post-operative week.
Cultures from the abscess, graft and blood produced
no growth. Despite this, the patient was treated with
four weeks of oral clindamycin (450 mg qds) and oral
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ciprofloxacin (500 mg bd) to be continued indefinitely.
He was discharge at three weeks and remains well to
follow up at one year (Fig. 2).
Discussion
The treatment of abdominal aortic aneurysms with
endovascular covered stent grafts has become widely
accepted. Zarins (2001)1 recently reported a series of 1192
patients treated using the AneuRx device. Survival was
86% and freedom from open conversion 93% at three
years. No infected grafts were reported. Infection of an
aortic stent graft with Listeria monocytogenes was
reported in a 77 years old man.2 The infected graft was
removed en bloc and replaced with an in situ aortoiliac
reconstruction. At 10 months follow-up the patient was
well with no signs of infection. Schlensak (2001)3
reported infected grafts in 5 of 150 patients treated
with stent grafts at 6.7–55.8 months post-procedure.
All devices were polyester covered nitinol. Patients
presented with fever, back and abdominal pain and
elevated CRP and white cell count. Despite negative
blood cultures patients were treated with broad-
spectrum antibiotics. CT scans revealed air entrapped
around the graft in three patients and thickened
aneurysm wall in direct contact with an intestinal loop
suggesting a fistula in the remaining two patients. All the
stent grafts were replaced with in situ Dacron grafts at
laparotomy. Tissue culture was positive for E. coli in one
patient but negative in the others raising the possibility
of an enteric fistula. Baker (2002)4 reported an aortic stent
graft infection with a positive blood culture for
bacteroides and enterococcus from the aneurysm sac.
This was treated with a staged extra-anatomic bypass
graft followed by graft excision. Graft infection from
open aneurysm repair is uncommon, Hayes (1999)5
treated 11 patients with graft excision and replacement
with in situ rifampicin-bonded grafts. At 2 years follow-
up 7 of 11 patients were alive and clinically free of
infection.
Infection of endovascular stent grafts is a rare but
extremely serious complication. This can occur at any
time interval from months to several years following
the initial procedure. We postulate that in this case the
aneurysm ruptured and the haematoma became
secondarily infected. Treatment of the infective grafts
has been explained and replacement with an in situ
Dacron graft, as in the case described. Cultures are
usually negative.
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Fig. 1. CT scan showing a contained rupture of the Talent
stent graft with pockets of gas around the infected stent graft.
Fig. 2. CT scan taken at 1 year following excision of infected
aortic stent graft and in situ replacement with a silver
impregnated Dacron graft. Note complete resolution of the
infective process with no evidence of gas or haematoma.
In Situ Silver Impregnated Dacron Replacement for an Infected Aortic Stent Graft: Case Report and Review of
the Literature
43
EJVES Extra Vol 5, 2003
